Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Phylogenetic Trees

Phylogenetic Trees

Phylogenetic trees come in many forms. It matters in which sequence the organisms are arranged from the bottom to the top of the tree, but the branches can rotate at their nodes without altering the information. The lines connecting individual nodes can be straight, angled, or even curved.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

SN1 Reaction: Stereochemistry

S_N1 Reaction: Stereochemistry

This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...

SN1 Reaction: Kinetics

S_N1 Reaction: Kinetics

In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...

SN1 Reaction: Mechanism

S_N1 Reaction: Mechanism

Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism.
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

Nature communications·2026

Same author

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Nature communications·2026

Same author

HIV serologic reactivity varies with time of ART initiation in persons on long-term ART.

Journal of clinical microbiology·2025

Same author

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.

bioRxiv : the preprint server for biology·2025

Same author

Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection.

bioRxiv : the preprint server for biology·2025

Same author

Bayesian estimation of HIV acquisition dates for prevention trials.

mBio·2025

Search research articles

Related Experiment Video

Updated: Jan 27, 2026

In vitro Uncoating of HIV-1 Cores

In vitro Uncoating of HIV-1 Cores

Published on: November 8, 2011

HIV-1 phylogenetics and vaccines.

Morgane Rolland^1,2

¹U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.

Current Opinion in HIV and AIDS

|March 30, 2019

Summary

Developing an effective HIV-1 vaccine is challenging due to viral diversity. Understanding HIV-1 genetic features is key to creating new vaccine strategies and broadly neutralizing antibodies.

More Related Videos

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Related Experiment Videos

Last Updated: Jan 27, 2026

In vitro Uncoating of HIV-1 Cores

In vitro Uncoating of HIV-1 Cores

Published on: November 8, 2011

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Area of Science:

Immunology
Virology
Genetics

Background:

HIV-1 genetic diversity presents a significant hurdle for vaccine development.
Current vaccine strategies have not fully addressed the specific genetic variations within HIV-1.

Purpose of the Study:

To discuss the interplay between HIV-1 phylogenetics and vaccine design.
To explore how understanding viral genetic specificities can inform HIV-1 vaccine strategies.

Main Methods:

Review of current vaccine efficacy trials.
Analysis of recent research on HIV-1 genetic features associated with broadly neutralizing antibodies.

Main Results:

Few genetically informed vaccine solutions have been evaluated due to a lack of protection correlates.
Recent findings illuminate viral features linked to the development of potent neutralizing antibodies.

Conclusions:

New avenues for engineering HIV-1 vaccine candidates are emerging based on viral genetic insights.
Future research must consider the potential for vaccine resistance and its population-level consequences.